Schedule 13D ownership disclosure

HERON THERAPEUTICS, INC.

Common Stock, par value $0.01 per share · CUSIP: 427746102

Event date: 2025-10-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Rubric Capital Management LPReported CIK 0001687509

    Shares: 30,046,828.00 · Class: 15.9%

  • David RosenReported CIK 0001898677

    Shares: 30,046,828.00 · Class: 15.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-004460
Form type
SCHEDULE 13D/A
Filer
HERON THERAPEUTICS, INC. /DE/
CIK
CIK 818033
Filed
Oct 17, 2025
Reporting period
Oct 15, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub